Skerjanec Simona 4

What Happened

• Simona Skerjanec, a director of IMMUNIC, Inc. (IMUX), was granted 25,370 derivative shares (an equity award) on July 5, 2026. The grant price is listed as $0.00, so no cash was paid for the award; the reported dollar value is $0. This is an award/acquisition of derivative securities rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-05; Form 4 filed: 2026-07-07.
• Instrument: Derivative securities (award/grant) — 25,370 shares acquired at $0.00.
• Total reported value: $0 (per filing).
• Vesting: Footnote F1 — vests in monthly increments over one year from the grant date.
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1 plan, tax withholding, or sale reported; filing appears timely (not flagged as late).

Context

• This transaction is a compensation-related equity award that vests over time, tying the grant to continued service. Such grants are common for executives and directors and do not necessarily indicate immediate buying or selling of stock in the market.